[CPHI] China Pharma Holdings, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.

 

Price: 0.25 Change: -0.01 (-3.81%)
Ext. hours: Change: 0 (0%)

chart CPHI

Refresh chart

Description: China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People?s Republic of China. It offers products in the form of dry powder injectibles, liquid injectibles, tablets, capsules, oral solutions, and granules. The company?s products are used for the treatment of central nervous system and cerebral-cardiovascular, anti-infection and respiratory, and digestive and other diseases. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and surgery-thrombus deep phlebitis; and Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and lipoprotein blood diseases. The company also provides Bumetanide to treat edema diseases; candesartan for hypertens

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -7.11% Sales Growth - Q/Q-7.02% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-25.27% ROE-32.03% ROI
Current Ratio3.28 Quick Ratio2.23 Long Term Debt/Equity0.34 Debt Ratio0.15
Gross Margin16.42% Operating Margin-130.05% Net Profit Margin-134.5% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-50 K Cash From Operating Activities Gross Profit1.06 M
Net Profit-7.97 M Operating Profit-7.67 M Total Assets125.16 M Total Current Assets48.11 M
Total Current Liabilities14.67 M Total Debt18.01 M Total Liabilities26.4 M Total Revenue5.69 M
Technical Data
High 52 week0.45 Low 52 week0.2 Last close0.3 Last change2.56%
RSI44.58 Average true range0.03 Beta0.51 Volume63.11 K
Simple moving average 20 days5.11% Simple moving average 50 days12.9% Simple moving average 200 days13.34%
Performance Data
Performance Week10.29% Performance Month6.35% Performance Quart-4% Performance Half29.87%
Performance Year-25% Performance Year-to-date16.55% Volatility daily3.16% Volatility weekly7.07%
Volatility monthly14.5% Volatility yearly50.22% Relative Volume69.27% Average Volume286.58 K
New High New Low

News

2019-01-08 12:58:13 | Top 3 Healthcare Penny Stocks for 2018

2018-11-23 08:55:00 | Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group — Discovering Underlying Factors of Influence

2018-11-15 06:00:00 | China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results

2018-11-13 08:00:00 | China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO®

2018-11-12 08:00:00 | CPHI to Hold Third Quarter 2018 Earnings Conference Call On Thursday, November 15, 2018 at 8:30 a.m. ET

2018-10-10 18:44:00 | Top 3 Healthcare Penny Stocks for 2018

2018-08-15 06:00:00 | China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results

2018-08-06 08:45:00 | CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET

2018-07-23 09:18:00 | Top 3 Healthcare Penny Stocks for 2018

2018-05-15 08:00:00 | Free Stock Performance Review on Pfizer and Three More Drug Makers’ Stocks

2018-05-15 06:00:00 | China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results

2018-05-11 09:10:00 | Top 3 Healthcare Penny Stocks for 2018

2018-05-08 08:00:00 | CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET

2018-04-06 07:40:00 | Wired News – Eli Lilly's Phase-3 REACH-2 Study of CYRAMZAR Met its Primary Endpoint of Overall Survival

2018-04-05 18:58:00 | Top 3 Healthcare Penny Stocks for 2018

2018-04-05 07:10:00 | Blog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSD

2018-04-03 06:00:00 | China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results

2018-03-22 08:00:00 | CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET

2018-03-11 16:15:00 | Top 3 Healthcare Penny Stocks for 2018

2018-02-08 09:52:00 | Top 3 Healthcare Penny Stocks for 2018

2018-01-07 19:20:00 | Top 3 Healthcare Penny Stocks for 2018

2017-12-10 15:59:00 | Top 3 Healthcare Penny Stocks for 2017

2017-12-01 07:58:53 | China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

2017-11-15 06:00:00 | China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results

2017-11-08 12:20:00 | Top 3 Healthcare Penny Stocks for 2017

2017-11-07 08:00:00 | CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET

2017-10-24 15:48:47 | Does China Pharma Holdings Inc’s CPHI Debt Level Pose A Serious Problem?

2017-10-13 19:05:00 | Top 3 Healthcare Penny Stocks for 2017

2017-09-26 12:03:12 | China Pharma Holdings Inc CPHI: What Does It Mean For Your Portfolio?

2017-09-14 07:40:00 | Corporate News Blog - GlaxoSmithKline Declares Publication of Phase-III Results Of Mepolizumab in Patients with Eosinophilic COPD at Risk of Exacerbations

2017-09-12 16:05:00 | China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency

2017-08-16 10:08:37 | China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

2017-08-15 06:00:00 | China Pharma Holdings, Inc. Reports Second Quarter 2017 Financial Results

2017-08-08 06:00:00 | CPHI to Hold Second Quarter 2017 Earnings Conference Call On Tuesday August 15, 2017 at 8:30 a.m. ET

2017-06-20 11:38:00 | Top 3 Healthcare Penny Stocks for 2017

2017-05-24 09:18:25 | China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

2017-05-19 08:00:00 | Top 3 Healthcare Penny Stocks for 2017

2017-05-17 08:30:00 | China Pharma Holdings, Inc.'s Wholly-owned Subsidiary Participated in PharmChina/API China Conferences

2017-05-12 06:00:00 | China Pharma Holdings, Inc. Reports First Quarter 2017 Financial Results

2017-05-08 06:00:00 | CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET

2017-04-04 08:41:40 | China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017

2017-03-31 06:11:56 | CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a

2017-03-31 06:00:00 | China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results

2017-03-27 06:00:00 | CPHI to Hold Fiscal Year 2016 Earnings Conference Call On Friday March 31, 2017 at 8:30 a.m. ET

2017-03-01 08:00:00 | Top 3 Healthcare Penny Stocks for 2017

2016-12-28 16:06:40 | CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Other Events

2016-12-13 16:08:19 | CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-12-02 16:11:42 | CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements a

2016-11-18 11:50:17 | China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016

2016-11-15 06:00:00 | China Pharma Holdings, Inc. Reports Third Quarter Financial Results